Association of Serum Lipoprotein-Associated Phospholipase A2 Level with Nonalcoholic Fatty Liver Disease


COLAK Y. , SENATES E. , OZTURK O., DOGANAY H. L. , Coskunpinar E., Oltulu Y. M. , ...More

METABOLIC SYNDROME AND RELATED DISORDERS, vol.10, no.2, pp.103-109, 2012 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 10 Issue: 2
  • Publication Date: 2012
  • Doi Number: 10.1089/met.2011.0111
  • Title of Journal : METABOLIC SYNDROME AND RELATED DISORDERS
  • Page Numbers: pp.103-109

Abstract

Background: Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and is one of the most common causes of chronic liver disease, worldwide. Lipoprotein-associated phospholipase A2 (Lp-PLA2) was recently characterized as a novel inflammatory biomarker that is correlated with several components constituting the metabolic syndrome.